首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Controlling False-Positive Results Obtained with the Hodge and Masuda Assays for Detection of Class A Carbapenemase in Species of Enterobacteriaceae by Incorporating Boronic Acid
【2h】

Controlling False-Positive Results Obtained with the Hodge and Masuda Assays for Detection of Class A Carbapenemase in Species of Enterobacteriaceae by Incorporating Boronic Acid

机译:控制掺入硼酸的肠杆菌科物种A类碳青霉烯酶的霍奇和增田测定获得的假阳性结果的控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The modified Hodge method (MHT) has been recommended by the CLSI for confirmation of suspected class A carbapenemase production in species of Enterobacteriaceae. This test and the Masuda method (MAS) have advantages over traditional phenotypic methods in that they directly analyze carbapenemase activity. In order to identify the potential interferences of these tests, we designed a panel composed of diverse bacterial genera with distinct carbapenem susceptibility patterns (42 carbapenemase producers and 48 nonproducers). About 25% of results among carbapenemase nonproducers, mainly strains harboring CTX-M and AmpC hyperproducers, were observed to be false positive. Subsequently, we developed an optimized approach for more-accurate detection of suspicious isolates of carbapenemase by addition of boronic acid (BA) derivatives (reversible inhibitor of class A carbapenemases and AmpC cephalosporinases) and oxacillin (inhibitor of AmpCs enzymes). The use of the modified BA- and oxacillin-based MHT and MAS resulted in high sensitivity (>90%) and specificity (100%) for class A carbapenemase detection. By use of these methodologies, isolates producing KPCs and GES, Sme, IMI, and NMC-A carbapenemases were successfully distinguished from those producing other classes of ß-lactamases (extended-spectrum β-lactamases [ESBLs], AmpC β-lactamases, metallo-β-lactamases [MBLs], etc.). These methods will provide the fast and useful information needed for targeting of antimicrobial therapy and appropriate infection control.
机译:CLSI已推荐使用改良的Hodge方法(MHT)来确认肠杆菌科物种中疑似A类碳青霉烯酶的产生。该测试和Masuda方法(MAS)优于传统的表型方法,因为它们可以直接分析碳青霉烯酶的活性。为了确定这些测试的潜在干扰,我们设计了一个由具有不同碳青霉烯敏感性模式(42个碳青霉烯酶生产者和48个非生产者)的不同细菌属组成的小组。碳青霉烯酶非生产者(主要是带有CTX-M和AmpC高生产者的菌株)中约25%的结果被观察为假阳性。随后,我们开发了一种优化方法,可通过添加硼酸(BA)衍生物(A类碳青霉烯酶和AmpC头孢菌素酶的可逆抑制剂)和奥沙西林(AmpCs酶的抑制剂)来更准确地检测碳青霉烯酶的可疑分离物。修饰的基于BA和奥沙西林的MHT和MAS的使用导致A类碳青霉烯酶检测的灵敏度高(> 90%)和特异性(100%)。通过使用这些方法,成功地将产生KPC和GES,Sme,IMI和NMC-A碳青霉烯酶的菌株与产生其他类别的β-内酰胺酶(超谱β-内酰胺酶[ESBLs],AmpCβ-内酰胺酶,金属酶-β-内酰胺酶[MBL]等)。这些方法将为靶向抗微生物治疗和适当的感染控制提供所需的快速有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号